Dietary intervention to maintain a consistent rectal volume for patients receiving radical radiotherapy to the prostate: A Randomised Study

Peter MacCallum Cancer Centre0 个研究点目标入组 30 人开始时间: 2010年2月5日最近更新: 2020年1月13日

适应症

试验速览

暂无简介。

•Patients 50 years of age or older, eligible for External Beam Radiotherapy (EBRT) for prostate cancer to a dose of at least 74Gy in 37 fractions.
•- Biopsy proven adenocarcinoma of the prostate, International Union against Cancer (UICC) TNM Classification of Malignant Tumours 6th edition stages T1-T3b.
•- Patients who will successfully received gold seed implants.
•- Eastern Cooperative Oncology Group (ECOG) performance status 0-2.
•- Ability to understand and the willingness to sign a written informed consent document.

•- Patients receiving radical salvage therapy post-prostatectomy.
•- Patients with a history of Irritable Bowel Syndrome (IBS)
•- Patients with a history of constipation in the 6 months prior to diagnosis or receiving opiate analgesics.
•- Patients with a concurrent or previous malignancy within 5 years prior to randomisation.
•- Patients having received prior radiotherapy to the pelvis.
•- Patients with dietary or medical requirements that will prevent them following the prescribed diet.
•- Patients receiving any other investigational agents that may impact upon this study.
•- Patients with other uncontrolled concurrent illnesses, psychiatric illness or social circumstance that may limit compliance with this study.
•- Prosthesis that may inhibit the visibility of the seeds – and possibly the prostate on Cone Beam Computed Tomography (CBCT) images.

发起方

Peter MacCallum Cancer Centre